Standout Papers

A Novel Role for 3-O-Sulfated Heparan Sulfate in Herpes Simplex ... 1987 2026 2000 2013 872
  1. A Novel Role for 3-O-Sulfated Heparan Sulfate in Herpes Simplex Virus 1 Entry (1999)
    Deepak Shukla, Jian Liu et al. Cell
  2. Entry of Alphaherpesviruses Mediated by Poliovirus Receptor-Related Protein 1 and Poliovirus Receptor (1998)
    Robert J. Geraghty, Claude Krummenacher et al. Science
  3. LIGHT, a New Member of the TNF Superfamily, and Lymphotoxin α Are Ligands for Herpesvirus Entry Mediator (1998)
    Davide Mauri, Reinhard Ebner et al. Immunity
  4. Three-dimensional structure of an antibody-antigen complex. (1987)
    S. Sheriff, Enid W. Silverton et al. Proceedings of the National Academy of Sciences

Immediate Impact

40 by Nobel laureates 43 from Science/Nature 66 standout
Sub-graph 1 of 20

Citing Papers

A multivalent nucleoside-modified mRNA vaccine against all known influenza virus subtypes
2022 StandoutScienceNobel
Chimeric spike mRNA vaccines protect against Sarbecovirus challenge in mice
2021 StandoutScienceNobel
3 intermediate papers

Works of Gary H. Cohen being referenced

An HSV-2 nucleoside-modified mRNA genital herpes vaccine containing glycoproteins gC, gD, and gE protects mice against HSV-1 genital lesions and latent infection
2020 Nobel
Nucleoside-modified mRNA encoding HSV-2 glycoproteins C, D, and E prevents clinical and subclinical genital herpes
2019 Nobel

Author Peers

Author Last Decade Papers Cites
Gary H. Cohen 13256 6620 4444 4485 239 19.0k
Roselyn J. Eisenberg 12311 6021 4020 3174 192 16.2k
Patricia G. Spear 14485 6710 5414 3825 156 19.9k
François–Loïc Cosset 7686 2149 5558 6688 283 18.2k
Jonathan W. Yewdell 9415 13877 2254 9608 258 25.2k
Richard W. Compans 11821 7725 3493 7294 465 26.3k
David M. Knipe 12297 7073 4385 4445 255 17.4k
Jack R. Bennink 6754 13445 2010 7752 211 21.1k
David C. Johnson 9551 4491 3103 2117 145 12.3k
Barry T. Rouse 7381 10035 1429 2978 373 17.3k
Theodore S. Jardetzky 5208 6746 1839 3696 155 14.9k

All Works

Loading papers...

Rankless by CCL
2026